Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: for those questioning analyst opinions of future share price ...

for those questioning analyst opinions of future share price ...

posted on Oct 17, 2007 10:26AM

There are those who questioned Dutton’s projected price and now Cohen’s projected price as being too conservative.  Bear in mind these analysts are trying to objectively look at the facts.  When J3 settle, they probably will issue another statement “reiterate strong buy” with a new projected price.  With each hurdle cleared by PTSC and TPL, the projected price will continue to go upwards imo.  Most of us already have J3 settlement, and other patent legal matters cleared up factored in our expected share price.  I personally can see that with a decent execution of growth plan, we should easily get past $5 and get listed on a major exchange.  I rather it take a little longer with higher probability of success than take a premature shot at it and miss.  Build the foundation and build.  I won’t mention my dream of over $20 till J3 settle.

Share
New Message
Please login to post a reply